Membrane Lipids Are an Integral Part of Transmembrane Allosteric Sites in GPCRs: A Case Study of Cannabinoid CB1 Receptor Bound to a Negative Allosteric Modulator, ORG27569, and Analogs

被引:14
作者
Obi, Peter [1 ]
Natesan, Senthil [1 ]
机构
[1] Washington State Univ, Coll Pharm & Pharmaceut Sci, Spokane, WA 99202 USA
基金
美国国家卫生研究院;
关键词
LIGAND-BINDING; MOLECULAR RECOGNITION; CONTINUUM SOLVENT; FREE-ENERGIES; FORCE-FIELD; INDOLE-2-CARBOXAMIDES; AFFINITY; DESOLVATION; MECHANISMS; PREDICTION;
D O I
10.1021/acs.jmedchem.2c00946
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A growing number of G-protein-coupled receptor (GPCR) structures reveal novel transmembrane lipid-exposed allosteric sites. Ligands must first partition into the surrounding membrane and take lipid paths to these sites. Remarkably, a significant part of the bound ligands appears exposed to the membrane lipids. The experimental structures do not usually account for the surrounding lipids, and their apparent contribution to ligand access and binding is often overlooked and poorly understood. Using classical and enhanced molecular dynamics simulations, we show that membrane lipids are critical in the access and binding of ORG27569 and its analogs at the transmembrane site of cannabinoid CB1 receptor. The observed differences in the binding affinity and cooperativity arise from the functional groups that interact primarily with lipids. Our results demonstrate the significance of incorporating membrane lipids as an integral component of transmembrane sites for accurate characterization, binding-affinity calculations, and lead optimization in drug discovery.
引用
收藏
页码:12240 / 12255
页数:16
相关论文
共 88 条
[21]  
Eswar Narayanan, 2007, Curr Protoc Protein Sci, VChapter 2, DOI [10.1002/0471250953.bi0506s15, 10.1002/cpbi.3, 10.1002/cpps.20, 10.1002/0471250953.bi0506s47, 10.1002/0471140864.ps0209s50]
[22]   The ins and outs of phospholipid asymmetry in the plasma membrane: roles in health and disease [J].
Fadeel, Bengt ;
Xue, Ding .
CRITICAL REVIEWS IN BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2009, 44 (05) :264-277
[23]   Validation of an automated procedure for the prediction of relative free energies of binding on a set of aldose reductase inhibitors [J].
Ferrari, Anna Maria ;
Degliesposti, Gianluca ;
Sgobba, Miriam ;
Rastelli, Giulio .
BIOORGANIC & MEDICINAL CHEMISTRY, 2007, 15 (24) :7865-7877
[24]   Embedded Mean-Field Theory [J].
Fornace, Mark E. ;
Lee, Joonho ;
Miyamoto, Kaito ;
Manby, Frederick R. ;
Miller, Thomas F., III .
JOURNAL OF CHEMICAL THEORY AND COMPUTATION, 2015, 11 (02) :568-580
[25]   Allosteric Modulation of GPCRs: New Insights and Potential Utility for Treatment of Schizophrenia and Other CNS Disorders [J].
Foster, Daniel J. ;
Conn, P. Jeffrey .
NEURON, 2017, 94 (03) :431-446
[26]   Heterogeneous Dielectric Implicit Membrane Model for the Calculation of MMPBSA Binding Free Energies [J].
Greene, D'Artagnan ;
Qi, Ruxi ;
Nguyen, Remy ;
Qiu, Tianyin ;
Luo, Ray .
JOURNAL OF CHEMICAL INFORMATION AND MODELING, 2019, 59 (06) :3041-3056
[27]   Strategy for Extending Half-life in Drug Design and Its Significance [J].
Gunaydin, Hakan ;
Altman, Michael D. ;
Ellis, J. Michael ;
Fuller, Peter ;
Johnson, Scott A. ;
Lahue, Brian ;
Lapointe, Blair .
ACS MEDICINAL CHEMISTRY LETTERS, 2018, 9 (06) :528-533
[28]   Predicting protein druggability [J].
Hajduk, PJ ;
Huth, JR ;
Tse, C .
DRUG DISCOVERY TODAY, 2005, 10 (23-24) :1675-1682
[29]   A specific cholesterol binding site is established by the 2.8 Å structure of the human β2-adrenergic receptor [J].
Hanson, Michael A. ;
Cherezov, Vadim ;
Griffith, Mark T. ;
Roth, Christopher B. ;
Jaakola, Veli-Pekka ;
Chien, Ellen Y. T. ;
Velasquez, Jeffrey ;
Kuhn, Peter ;
Stevens, Raymond C. .
STRUCTURE, 2008, 16 (06) :897-905
[30]   Understanding the diversity of membrane lipid composition [J].
Harayama, Takeshi ;
Riezman, Howard .
NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2018, 19 (05) :281-296